Calamos Advisors
BMEZ icon

Calamos Advisors’s BlackRock Health Sciences Trust II BMEZ Stock Holding History

Calamos Advisors’s Portfolio BMEZ Stock Details BMEZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.33M Buy
79,371
+24,128
+44% +$390K ﹤0.01% 736
2026
Q2 		$848K Buy
55,243
+3,684
+7% +$53K ﹤0.01% 773
2026
Q1 		$740K Buy
+51,559
New +$766K ﹤0.01% 844

Other funds holding BMEZ

Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $64.1B AUM 28.9% 1-Year Est. Return
RFG Advisory
RFG Advisory Birmingham, Alabama $7.09B AUM 12.79% 1-Year Est. Return
City of London Investment Management
City of London Investment Management London, United Kingdom $1.47B AUM 36.54% 1-Year Est. Return
Oppenheimer & Co
Oppenheimer & Co New York $9.5B AUM 27.65% 1-Year Est. Return
Blue Bell Private Wealth Management
Blue Bell Private Wealth Management Blue Bell, Pennsylvania $840M AUM 13.7% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return
TrueMark Investments
TrueMark Investments Chicago, Illinois $856M AUM 21.72% 1-Year Est. Return
Apollon Wealth Management
Apollon Wealth Management Mount Pleasant, South Carolina $8.72B AUM 23.07% 1-Year Est. Return
Indivisible Partners
Indivisible Partners Clearwater, Florida $2.18B AUM 33.61% 1-Year Est. Return
Kestra Advisory Services
Kestra Advisory Services Austin, Texas $35.1B AUM 20.13% 1-Year Est. Return

Calamos Advisors's BMEZ Position: Q3 2026 in Review

Calamos Advisors increased its BlackRock Health Sciences Trust II (BMEZ) stake by 44% in Q3 2026, buying an estimated $390K and bringing the position to 79,371 shares worth $1.33M. The position accounts for ﹤0.01% of the portfolio, ranked #736.

Calamos Advisors first reported a position in BMEZ in Q1 2026 and has held it in 3 quarters since. 40 funds tracked by Wall St. Rank hold BMEZ as of Q3 2026.

  • Calamos Advisors held 79,371 shares of BlackRock Health Sciences Trust II worth $1.33M as of Q3 2026.
  • Calamos Advisors bought 24,128 BlackRock Health Sciences Trust II shares in Q3 2026, an estimated $390K.
  • BlackRock Health Sciences Trust II made up ﹤0.01% of Calamos Advisors's portfolio in Q3 2026, its #736 holding.
  • Calamos Advisors first reported a position in BlackRock Health Sciences Trust II in Q1 2026 and has held it in 3 quarters since.
  • 40 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust II as of Q3 2026.

Based on Calamos Advisors's 13F filing for Q3 2026, filed 2 Nov 2026.